These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 27754314)

  • 1. Biodegradable Polymeric Nanoparticles-Based Vaccine Adjuvants for Lymph Nodes Targeting.
    Gutjahr A; Phelip C; Coolen AL; Monge C; Boisgard AS; Paul S; Verrier B
    Vaccines (Basel); 2016 Oct; 4(4):. PubMed ID: 27754314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PLGA particulate delivery systems for subunit vaccines: Linking particle properties to immunogenicity.
    Silva AL; Soema PC; Slütter B; Ossendorp F; Jiskoot W
    Hum Vaccin Immunother; 2016 Apr; 12(4):1056-69. PubMed ID: 26752261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beyond antigens and adjuvants: formulating future vaccines.
    Moyer TJ; Zmolek AC; Irvine DJ
    J Clin Invest; 2016 Mar; 126(3):799-808. PubMed ID: 26928033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. pH-Responsive Poly(D,L-lactic-co-glycolic acid) Nanoparticles with Rapid Antigen Release Behavior Promote Immune Response.
    Liu Q; Chen X; Jia J; Zhang W; Yang T; Wang L; Ma G
    ACS Nano; 2015 May; 9(5):4925-38. PubMed ID: 25898266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Poly(lactic acid)-based particulate systems are promising tools for immune modulation.
    Peres C; Matos AI; Conniot J; Sainz V; Zupančič E; Silva JM; Graça L; Sá Gaspar R; Préat V; Florindo HF
    Acta Biomater; 2017 Jan; 48():41-57. PubMed ID: 27826003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Particulate formulations for the delivery of poly(I:C) as vaccine adjuvant.
    Hafner AM; Corthésy B; Merkle HP
    Adv Drug Deliv Rev; 2013 Oct; 65(10):1386-99. PubMed ID: 23751781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvants and delivery systems based on polymeric nanoparticles for mucosal vaccines.
    Jin Z; Gao S; Cui X; Sun D; Zhao K
    Int J Pharm; 2019 Dec; 572():118731. PubMed ID: 31669213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Development of vaccine adjuvants using polymeric nanoparticles and their potential applications for anti-HIV vaccine].
    Akagi T; Baba M; Akashi M
    Yakugaku Zasshi; 2007 Feb; 127(2):307-17. PubMed ID: 17268151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent Advances and Future Perspectives in Polymer-Based Nanovaccines.
    Pippa N; Gazouli M; Pispas S
    Vaccines (Basel); 2021 May; 9(6):. PubMed ID: 34073648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-delivery of Dual Toll-Like Receptor Agonists and Antigen in Poly(Lactic-Co-Glycolic) Acid/Polyethylenimine Cationic Hybrid Nanoparticles Promote Efficient
    Ebrahimian M; Hashemi M; Maleki M; Hashemitabar G; Abnous K; Ramezani M; Haghparast A
    Front Immunol; 2017; 8():1077. PubMed ID: 28955328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angelica sinensis polysaccharide encapsulated into PLGA nanoparticles as a vaccine delivery and adjuvant system for ovalbumin to promote immune responses.
    Gu P; Liu Z; Sun Y; Ou N; Hu Y; Liu J; Wu Y; Wang D
    Int J Pharm; 2019 Jan; 554():72-80. PubMed ID: 30399435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid and Persistent Delivery of Antigen by Lymph Node Targeting PRINT Nanoparticle Vaccine Carrier To Promote Humoral Immunity.
    Mueller SN; Tian S; DeSimone JM
    Mol Pharm; 2015 May; 12(5):1356-65. PubMed ID: 25817072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjuvanting a Simian Immunodeficiency Virus Vaccine with Toll-Like Receptor Ligands Encapsulated in Nanoparticles Induces Persistent Antibody Responses and Enhanced Protection in TRIM5α Restrictive Macaques.
    Kasturi SP; Kozlowski PA; Nakaya HI; Burger MC; Russo P; Pham M; Kovalenkov Y; Silveira ELV; Havenar-Daughton C; Burton SL; Kilgore KM; Johnson MJ; Nabi R; Legere T; Sher ZJ; Chen X; Amara RR; Hunter E; Bosinger SE; Spearman P; Crotty S; Villinger F; Derdeyn CA; Wrammert J; Pulendran B
    J Virol; 2017 Feb; 91(4):. PubMed ID: 27928002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A strong adjuvant based on glycol-chitosan-coated lipid-polymer hybrid nanoparticles potentiates mucosal immune responses against the recombinant Chlamydia trachomatis fusion antigen CTH522.
    Rose F; Wern JE; Gavins F; Andersen P; Follmann F; Foged C
    J Control Release; 2018 Feb; 271():88-97. PubMed ID: 29217176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccine Adjuvants: from 1920 to 2015 and Beyond.
    Di Pasquale A; Preiss S; Tavares Da Silva F; Garçon N
    Vaccines (Basel); 2015 Apr; 3(2):320-43. PubMed ID: 26343190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune system targeting by biodegradable nanoparticles for cancer vaccines.
    Silva JM; Videira M; Gaspar R; Préat V; Florindo HF
    J Control Release; 2013 Jun; 168(2):179-99. PubMed ID: 23524187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biodegradable polymer microspheres as vaccine adjuvants and delivery systems.
    Gupta RK; Chang AC; Siber GR
    Dev Biol Stand; 1998; 92():63-78. PubMed ID: 9554260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carbonate Apatite Nanoparticles Act as Potent Vaccine Adjuvant Delivery Vehicles by Enhancing Cytokine Production Induced by Encapsulated Cytosine-Phosphate-Guanine Oligodeoxynucleotides.
    Takahashi H; Misato K; Aoshi T; Yamamoto Y; Kubota Y; Wu X; Kuroda E; Ishii KJ; Yamamoto H; Yoshioka Y
    Front Immunol; 2018; 9():783. PubMed ID: 29720976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rational Design of PLGA Nanoparticle Vaccine Delivery Systems To Improve Immune Responses.
    Gu P; Wusiman A; Zhang Y; Liu Z; Bo R; Hu Y; Liu J; Wang D
    Mol Pharm; 2019 Dec; 16(12):5000-5012. PubMed ID: 31621331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of two different PEGylation strategies for the liposomal adjuvant CAF09: Towards induction of CTL responses upon subcutaneous vaccine administration.
    Schmidt ST; Olsen CL; Franzyk H; Wørzner K; Korsholm KS; Rades T; Andersen P; Foged C; Christensen D
    Eur J Pharm Biopharm; 2019 Jul; 140():29-39. PubMed ID: 31055066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.